Methotrexate emerges as alternative first-line treatment for pulmonary sarcoidosis
While prednisone is the standard first-line treatment for pulmonary sarcoidosis, side effects can diminish quality of life. Researchers report that methotrexate appears to have fewer side effects and… read more.